- Home
- PSF vs ARAY Comparison
PSF vs ARAY Comparison
Compare PSF & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSF
- ARAY
- Stock Information
- Founded
- PSF 2010
- ARAY 1990
- Country
- PSF United States
- ARAY United States
- Employees
- PSF N/A
- ARAY N/A
- Industry
- PSF Investment Managers
- ARAY Medical/Dental Instruments
- Sector
- PSF Finance
- ARAY Health Care
- Exchange
- PSF Nasdaq
- ARAY Nasdaq
- Market Cap
- PSF 244.3M
- ARAY 229.3M
- IPO Year
- PSF N/A
- ARAY 2007
- Fundamental
- Price
- PSF $18.94
- ARAY $1.48
- Analyst Decision
- PSF
- ARAY
- Analyst Count
- PSF 0
- ARAY 0
- Target Price
- PSF N/A
- ARAY N/A
- AVG Volume (30 Days)
- PSF 25.0K
- ARAY 607.8K
- Earning Date
- PSF 01-01-0001
- ARAY 04-30-2025
- Dividend Yield
- PSF 7.69%
- ARAY N/A
- EPS Growth
- PSF N/A
- ARAY N/A
- EPS
- PSF N/A
- ARAY N/A
- Revenue
- PSF N/A
- ARAY $453,140,000.00
- Revenue This Year
- PSF N/A
- ARAY $6.97
- Revenue Next Year
- PSF N/A
- ARAY $5.02
- P/E Ratio
- PSF N/A
- ARAY N/A
- Revenue Growth
- PSF N/A
- ARAY 1.26
- 52 Week Low
- PSF $16.00
- ARAY $1.40
- 52 Week High
- PSF $20.19
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- PSF 42.48
- ARAY 32.59
- Support Level
- PSF $18.51
- ARAY $1.42
- Resistance Level
- PSF $18.94
- ARAY $1.55
- Average True Range (ATR)
- PSF 0.46
- ARAY 0.11
- MACD
- PSF -0.01
- ARAY -0.01
- Stochastic Oscillator
- PSF 44.89
- ARAY 15.91
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.